Synopsis:
The purpose of this study was to determine the synergistic
activity of amikacin, ertapenem and fluoroquinolones
combinations against resistant nosocomial
pathogens. The antibiotic combinations showed additive
or synergistic activity against many of the Gramnegative
pathogens.